Microba Life Sciences Limited
Microba Life Sciences Limited
Your view on MAP.AX
Overview
What the company does, where it operates, and who runs it.
About Microba Life Sciences Limited
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Luke Reid
- Headquarters
- 324 Queen Street, Brisbane, QLD, AU
- Industry
- Medical - Diagnostics & Research
- Sector
- Healthcare
- CEO
- Luke Reid
- Headquarters
- 324 Queen Street, Brisbane, QLD, AU
Microba Life Sciences Limited, established in Brisbane, Australia, in 2017, specializes in providing sophisticated microbiome testing and analytical services.
These offerings reach clinicians, individual consumers, and research customers across key international markets, including Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, and the United States. The company delivers pathology, therapeutic, and diagnostic solutions deeply rooted in human gut microbiome science.
Central to its operations is a comprehensive Databank, invaluable for unearthing therapeutic leads, fostering consumer health advancements, and identifying crucial diagnostic biomarkers.
Moreover, Microba leverages a data-driven therapeutics platform to engineer innovative monoclonal microbial cell therapies aimed at treating inflammatory bowel disease, enhancing cancer immunotherapy, and managing autoimmune disorders.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Microba Life Sciences Limited. Starting points for Microba Life Sciences Limited: EPS -AUD 0.03, beta 2.06 — an Medical - Diagnostics & Research name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Microba Life Sciences Limited. Microba Life Sciences Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Microba Life Sciences Limited. Trailing twelve-month EPS for Microba Life Sciences Limited stands at -AUD 0.03. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Wall Street Analyst Estimates
Analysts' price targets, ratings, and revenue and EPS estimates.
Earnings per share estimates
| Per share | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 0.00 | −AUD 0.01 | −AUD 0.02 | −AUD 0.01 |
| Lowest estimate | AUD 0.00 | −AUD 0.01 | −AUD 0.02 | −AUD 0.01 |
| Highest estimate | AUD 0.00 | −AUD 0.01 | −AUD 0.02 | −AUD 0.01 |
| Number of analysts | 0 | 1 | 1 | 1 |
| A year ago | — | — | −AUD 0.031 | — |
| Growth vs a year ago | — | — | — | — |
1The year-ago figure includes one-time items, so growth is not shown.
Revenue estimates
| Total | This quarterSep 2025 | Next quarterDec 2025 | This yearYear to Jun 2027 | Next yearYear to Jun 2028 |
|---|---|---|---|---|
| Average estimate | AUD 8.29M | AUD 8.20M | AUD 15.36M | AUD 19.78M |
| Lowest estimate | AUD 8.29M | AUD 8.20M | AUD 15.36M | AUD 19.78M |
| Highest estimate | AUD 8.29M | AUD 8.20M | AUD 15.36M | AUD 19.78M |
| Number of analysts | 1 | 1 | 1 | 1 |
| A year ago | — | — | AUD 14.76M | — |
| Growth vs a year ago | — | — | +4.1% | — |
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Microba Life Sciences Limited. Microba Life Sciences Limited has reported as a listed company since 2022. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Industry | |
|---|---|---|---|---|---|
| AGN.AXArgenica Therapeutics Ltd | Healthcare | Biotechnology | — | ||
| BDX.AXBCAL Diagnostics Limited | Healthcare | Medical - Diagnostics & Research | — | ||
| EMD.AXEmyria Limited | Healthcare | Medical - Healthcare Information Services | — | ||
| EYE.AXNova Eye Medical Limited | Healthcare | Medical - Devices | — | ||
| HMD.AXHeraMED Limited | Healthcare | Medical - Devices | — | ||
| IDT.AXIDT Australia Limited | Healthcare | Drug Manufacturers - Specialty & Generic | — | ||
| IIQ.AXINOVIQ Ltd | Healthcare | Medical - Diagnostics & Research | — | ||
| NOX.AXNoxopharm Limited | Healthcare | Biotechnology | — | ||
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| GSS.AXGenetic Signatures Limited | Healthcare | ASX | — | ||
| HLS.AXHealius Limited | Healthcare | ASX | — | ||
| HTGMQHTG Molecular Diagnostics, Inc. | Healthcare | OTC | $221 | ||
| IBX.AXImagion Biosystems Limited | Healthcare | ASX | — | ||
| IBXXFImagion Biosystems Limited | Healthcare | OTC | $2.2M | ||
| ICBUiMD Companies, Inc. | Healthcare | OTC | $7.7M | ||
| ICLRICON Public Limited Company | Healthcare | NASDAQ | $14.6B | ||
| IDGXFIntegrated Diagnostics Holdings plc | Healthcare | OTC | $372.0M | ||
| IDX.AXIntegral Diagnostics Limited | Healthcare | ASX | — | ||
| IDXGInterpace Biosciences, Inc. | Healthcare | OTC | $7.7M | ||
| IDXXIDEXX Laboratories, Inc. | Healthcare | NASDAQ | $55.0B | ||
| IHTIIntegrative Health Technologies, Inc. | Healthcare | OTC | $32,514 | ||
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Microba Life Sciences Limited. Coverage tracks Microba Life Sciences Limited within Medical - Diagnostics & Research (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Microba Life Sciences Limited.